NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Caresyntax

Caresyntax

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://caresyntax.com/US/

Last Round

Debt

Aug 15, 2024

Total Funding Raised

$325M

Company Overview

Caresyntax is a healthcare technology company that provides a vendor-neutral, AI-powered surgical intelligence platform designed to improve patient outcomes and operational efficiency in operating rooms.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Data Integration

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

surgical intelligenceprecision surgerysurgical dataoperating room integrationORIreal world evidenceRWEclinical data as a serviceCDaaSsurgical video analyticsrobotic surgery platformsurgical workflowmedtech analyticssurgical AIdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Caresyntax Comps

Public and private peers based on sector, stage, and business model.

Caresyntax comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Caresyntax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtAug 15, 2024
Series CFeb 14, 2024
Series C ExtensionSep 16, 2021
Series CApr 28, 2021
Series BDec 17, 2019
Debt
Jul 1, 2019

Key People

Founding team and executive leadership

Matt Krueger

Chief Executive Officer

Executive Team

Ronan Blanchard

CFO, Chief Financial Officer

Executive Team

Caresyntax Investors

Notable investors and investment history

Caresyntax investors
InvestorRounds
Norgine VenturesDebt
NovacapSeries C Extension
IPF PartnersDebt, Series C Extension, Series C, Series B
Plug and Play Tech CenterDebt, Series B
Almak CapitalSeries B
Cure Capital AdvisorsDebt
Lauxera Capital PartnersDebt, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 25, 2025

    Launched Clinical Data as a Service (CDaaS) for healthcare and life sciences.

  • Sep 8, 2025

    Partnered with Paragonix Technologies to expand Real-World Evidence in transplantation.

Caresyntax Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Caresyntax Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Caresyntax's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range136
Year Founded2013
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.